GB Group Ord Shs GBGPF

Based on current....

[thorgb1]

ACB share price we are getting 3.315 shares of ACB for each CMED share. Remember, 3 weeks ago ACB was $3......

[IRWeldr]

The SP's started going up at roughly the same time. On Oct 27th (start of upward trend for both companies) ACB was about $2.90 and CMED was about $11.70. 4.5 (to keep the math easy)shares of ACB would be $13.05 per CMED share which is an 11% premium. About 1 week later Nov 3rd (huge run starts for both companies) ACB $3.10 CMED $12.90. 4.5 shares of ACB would have been $13.95. 8% premium. Nov.

[HopefulJuan]

Deal will never get done. Quarterly earnings will bring to light the value of CMED. Put my shares up for $56 for now and will wait for March. Liking the easy to trust poster perspective from a poster who has been on the board from day 1. Some of the guys showing up lately not so cool. Good luck to all

[BobTBuilder]

It's based on 20 day volume weighted average price not current share price.  So if the 20 day VWAP was currently $6 and the conditions were met today you would get 4 ACB shares. Which would be worth $28.96. "the number of Aurora Shares that a holder of CanniMed Shares will receive will be calculated by dividing the Cap Price of $24.00 by the Calculation Date VWAP."

[BobTBuilder]

Also just to avoid confusion the 20 day VWAP = calculation date VWAP. I realize I left that part out. "The Offer will provide holders of CanniMed Shares with 4.52586207 Aurora Shares for each CanniMed Share, subject to a maximum of $24.00 (the "Cap Price") in Aurora Shares. If, on the earlier of the expiry time of the Offer and the date on which all conditions to the

[thorgb1]

No offence Bob, but you don't have shares of CMED, so I don't really care what your opinion is. It's really funny the number of ACB shills on this board who are pushing us to accept it, while on the ACB  board they are all complaining about the value.  My take is that this isn't over by a long shot. I question the validity of the lockup agreement, and honestly wonder how

[BobTBuilder]

I think I understand. My opinion is invalid because I don't own CMED shares. Just like a male OBGYN's opinion on the female reproductive system is also invalid. It makes perfect sense. Thank you so much for sharing your profound opinion with me. I'm just such an ACB shill I got confused and thought I was just trying to help. The mistake will not be repeated.

[dogger05]

thank you for not making me listen to more B.S.....acb is overvalued and Cmed is undervalued. If that’s not your opinion then you don’t know what makes a good equity investment

[VENMan]

This by no means had to be a hostile takeover. When ACB reached out to CMED one person did not even want to pick up the phone and even talk about the possibilty of a friendly merger. So how is that working in the best interest of all Shareholders. When the market knew an offer was forth coming again one person at CMED would not even entertain the idea of simply talking. How is that in the best

[VENMan]

What's interesting is in the 104 page BID to OFFER  that CMED put out on sadar, it states I think, that ACB made a call to CMED on Nov 6 2017 with regards to wanting to talk about a possible merger, I think and on Nov 7 IROC halted HIP on trading activity, I think. So please help me understand who is working in who's best interest here, again? ALL IMO ! Always do your own due

[thorgb1]

I don't disagree with you at all. CMED is not without blame in this mess either, but I think you may have answered your own question above. If ACB approached CMED at a time when they were in advanced discussions to acquire HIP, it is only logical that CMED would not want to entertain any discussions until such a time as they had concluded their discussions with HIP. I have heard rumours as

[Stonyguy]

If your understanding that WEED and APH previously expressed interest, and to have them potentially thwart this offer.  The SP and company will be relegated to the lower end of the food chain.  Possibly even affecting their ability to raise capital in the future, as they will have not demonstrated good corporate leadership.  Do you think the likes of Cancord will have an easy time

[VENMan]

I think CMED was not in advanced discussions to acquire HIP at all. It was only after ACB approched CMED on Nov 6 and perhaps early by CGC and APH that CMED reached out to HIP on Nov 7. CMED should have first concluded their discussions with ACB and even perhaps CGC and APH earlier on; before starting discussion with HIP. I think when Shareholders saw that CGC, APH and finally ACB received no

[thorgb1]

i don't believe your assumption is accurate. In June CMED put out an investor deck that indicated they would be moving towards the rec market. On Oct. 4th, Brent mentioned at the Eight Capital investors conference that CMED would be players in the rec space within 30 days, so I don't believe he would be stating such if they had not been in discussions with a third party on an acquisition

[VENMan]

thorgb1, I always respect your opinion. thank you for your input and views, many kind regards

[Skater]

thorgb1, completely agree with you, if an offer comes in higher, wouldn't those directors be open to litigation as they've locked up their shares at a lower price? I agree with you, don't care who the buyer is, just want the best value. Perhaps it is ACB's offer, but with out exploring it...also what about an alcohol or tobacco player or big pharma coming with an investment now

[Stonyguy]

I think the point of the lock-up agreement, and the shareholders that have signed it, agree that no other offer was or is expected to be forthcoming.  What I understand the groups of 38% approached ACB, and for all intents and purposes one of them was a director.  I see a very disappointing EPS from CMED and that will take a year or so to sort out (IMHO), that does not reflect well for

[thorgb1]

The market is not overly concerned with EPS at this point, profitability should be coming though. The primary reason CMED has lagged behind the sector has always been their reluctance to signal in anyway that they were going to play in the rec space. That changed when Brent addressed the Eight Capital conference and signalled that they would be making an entry into the rec market, which not

[Stonyguy]

Just as an observation, I have read a number of times, SP is currently based on future value, so ACB is going up now based on all future production, causing criticism of the SP.  Then yourself (as an example) say “The market is not overly concerned with EPS at this point, profitability should be coming though.” Many are saying here that CMED is fairly valued and ACB is not.  However ACB